[Association of intraocular neovascular disease and innate immune response].
Sonoda
Koh-Hei
KH
Department of Ophthalmology, Graduate School of Medical Science, Kyushu University.
Ismbashi
Tatsuro
T
D000818:Animals; D018949:Antigens, CD1; D020256:Choroidal Neovascularization / Q000188:drug therapy / Q000276:immunology*; D005699:Galactosylceramides / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007113:Immunity, Innate; D015850:Interleukin-6; D007694:Killer Cells, Natural / Q000276:immunology; D008264:Macrophages / Q000276:immunology; D051379:Mice; D013601:T-Lymphocytes / Q000276:immunology; D042461:Vascular Endothelial Growth Factor A / Q000096:biosynthesis
C487652:2-amino-1-galactopyranosyloxy-3,4-dihydroxyoctadecane; D018949:Antigens, CD1; D005699:Galactosylceramides; D015850:Interleukin-6; D042461:Vascular Endothelial Growth Factor A